Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3046% below fair value
$24.66−0.19 (-0.76%)
Close on Nov 13, 2026Market cap $678.53MP/E –Yield –
Fulgent Genetics operating margin
Operating margin is operating income as a percentage of revenue.
Fulgent Genetics's operating margin for the twelve months ending Sep 30, 2026 was -39.2%. For fiscal 2025 it was -28.2%, against -26.1% the year before. The highest annual figure on record is 68.8% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -28.2% | −2.2 |
| FY2024 | Dec 31, 2024 | -26.1% | +41.5 |
| FY2023 | Dec 31, 2023 | -67.6% | −96.4 |
| FY2022 | Dec 31, 2022 | 28.8% | −39.3 |
| FY2021 | Dec 31, 2021 | 68.1% | −0.7 |
| FY2020 | Dec 31, 2020 | 68.8% | +70.1 |
| FY2019 | Dec 31, 2019 | -1.3% | +22.4 |
| FY2018 | Dec 31, 2018 | -23.7% | −5.2 |
| FY2017 | Dec 31, 2017 | -18.6% | −23.6 |
| FY2016 | Dec 31, 2016 | 5.0% | +57.4 |
| FY2015 | Dec 31, 2015 | -52.3% | +25.1 |
| FY2014 | Dec 31, 2014 | -77.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -24.9% | −6.7 |
| Q2 FY2026 | Jun 30, 2026 | -42.2% | −18.1 |
| Q1 FY2026 | Mar 31, 2026 | -48.7% | −21.7 |
| Q4 FY2025 | Dec 31, 2025 | -43.5% | −22.3 |
| Q3 FY2025 | Sep 30, 2025 | -18.3% | +5.5 |
| Q2 FY2025 | Jun 30, 2025 | -24.1% | +2.5 |
| Q1 FY2025 | Mar 31, 2025 | -26.9% | +6.9 |
| Q4 FY2024 | Dec 31, 2024 | -21.2% | +193.2 |
| Q3 FY2024 | Sep 30, 2024 | -23.8% | −24.1 |
| Q2 FY2024 | Jun 30, 2024 | -26.6% | +2.6 |
| Q1 FY2024 | Mar 31, 2024 | -33.8% | +3.7 |
| Q4 FY2023 | Dec 31, 2023 | -214.3% | −160.4 |
| Q3 FY2023 | Sep 30, 2023 | 0.3% | −0.1 |
| Q2 FY2023 | Jun 30, 2023 | -29.2% | −39.4 |
| Q1 FY2023 | Mar 31, 2023 | -37.5% | −100.6 |
| Q4 FY2022 | Dec 31, 2022 | -54.0% | −113.9 |
| Q3 FY2022 | Sep 30, 2022 | 0.3% | −69.6 |
| Q2 FY2022 | Jun 30, 2022 | 10.2% | −54.2 |
| Q1 FY2022 | Mar 31, 2022 | 63.1% | −11.2 |
| Q4 FY2021 | Dec 31, 2021 | 59.9% | −16.6 |
| Q3 FY2021 | Sep 30, 2021 | 69.9% | +7.4 |
| Q2 FY2021 | Jun 30, 2021 | 64.4% | +49.1 |
| Q1 FY2021 | Mar 31, 2021 | 74.3% | +99.0 |
| Q4 FY2020 | Dec 31, 2020 | 76.6% | +81.5 |
| Q3 FY2020 | Sep 30, 2020 | 62.5% | +47.9 |
| Q2 FY2020 | Jun 30, 2020 | 15.3% | +11.8 |
| Q1 FY2020 | Mar 31, 2020 | -24.7% | +9.3 |
| Q4 FY2019 | Dec 31, 2019 | -4.9% | +13.3 |
| Q3 FY2019 | Sep 30, 2019 | 14.6% | +29.6 |
| Q2 FY2019 | Jun 30, 2019 | 3.5% | +22.0 |
| Q1 FY2019 | Mar 31, 2019 | -33.9% | +13.2 |
| Q4 FY2018 | Dec 31, 2018 | -18.1% | +30.2 |
| Q3 FY2018 | Sep 30, 2018 | -15.0% | +17.8 |
| Q2 FY2018 | Jun 30, 2018 | -18.5% | −15.3 |
| Q1 FY2018 | Mar 31, 2018 | -47.2% | −51.3 |
| Q4 FY2017 | Dec 31, 2017 | -48.4% | −69.9 |
| Q3 FY2017 | Sep 30, 2017 | -32.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -3.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 4.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 21.5% | – |
See a number that looks wrong?